Scientific rigour that doesn't read like a package insert.
Educational and promotional content for professionals and patients, produced with the evidence up front and the craft intact.
Why this rarely works
Healthcare material tends to land at one of two extremes. Either it's rigorous and nobody reads it, because it reads like an expanded package insert. Or it's compelling and doesn't survive review, because getting there required saying too much.
The middle exists, and it isn't an average of the two: it's understanding what the evidence says and finding the way to tell it that doesn't exceed it. That requires the writer to understand the data, not copy it.
What's included
Materials for healthcare professionals
Visual aids, congress materials, field-force content and medical communications, with verified references.
Content for patients and caregivers
Educational, adherence and support-programme material, in accessible register and without promising outcomes.
Audiovisual and visual production
Video, motion, photography, scientific illustration, 3D and product and packaging renders.
Adaptation and localization
Global assets taken to local market. This isn't translation: claims, legal copy, units, references and sometimes the whole concept change.
Why us
Every asset goes through medical and regulatory validation before it ships, and that review sits inside the creative process rather than after it. That's why a concept that can't be supported gets dropped at the cheap stage, while it's still an idea and not finished artwork.
Questions we get
Do you use AI to produce?
Yes, and we declare it. We use it where it adds — variants, adaptations, fast iteration — and skip it where it subtracts. In healthcare there's one additional line we don't negotiate: no generated image depicts a clinical outcome, a real patient, or an identifiable professional.
Who validates the scientific references?
They're checked against the primary source and the approved labeling before the asset enters design. A reference you can't open and read doesn't make it in.
Can you adapt material that's already globally approved?
It's a large part of the work. The difficulty isn't language — it's that global approval doesn't equal local approval, and some claims hold in one market and not in another.
The other services
regulatory compliance
Medical and legal validation of every asset, by market and by brand, built into production instead of bolted on at the end.
See the service → 02strategic consulting
Brand, audiences, channels and competitors, analysed inside the real regulatory frame of the product and the market it will run in.
See the service → 04omnichannel and engagement
Communication journeys for professionals and patients, coordinated across channels and measured end to end.
See the service → 05paid media and performance
Search, social and programmatic inside each platform's health policies, with no sensitive data ever entering a pixel.
See the service →